GLI1 and neoplasm: Illustratively, a window-of-opportunity study using high-dose itraconazole reported reductions in tumor volume and pro-angiogenic factors but no corresponding downregulation of Hh target genes like GLI1 and PTCH106, implying that the observed effects may be off-target or that Hh signaling was not sufficiently suppressed.